UK government to cut cost of repeatable HRT prescriptions
HRT treats menopause symptoms by replacing hormones that are at a lower level for those experiencing it
Read More
Tag: Women’s health
Organon and ObsEva to collaborate on preterm labour treatment
Organon will license the global development, manufacturing and commercial rights to investigational treatment ebopiprant
Read More
Teva sells off women’s health assets for $1.38bn
Teva has sold the remaining assets in its speciality global women’s health portfolio for $1.38 billion.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
